On the recordJuly 26, 2021
Nearly two years into the COVID-19 pandemic access to the COVID-19 vaccine in poor and developing nations remains a challenge.
Source
congress.govNearly two years into the COVID-19 pandemic access to the COVID-19 vaccine in poor and developing nations remains a challenge.
Menendez highlights vaccine access issues in developing countries during the pandemic.
Share
More from Bob Menendez
I feel like that voice is lost. And I think it is something that is critically important to make sure that they are a part of the process.
From your perspective, how has Boeing historically and more recently handled the tension between prioritizing safety while also being a moneymaking enterprise?